Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.01 - $28.55 $135,759 - $168,445
-5,900 Reduced 43.38%
7,700 $215,000
Q2 2024

Aug 14, 2024

SELL
$23.21 - $27.24 $164,791 - $193,404
-7,100 Reduced 34.3%
13,600 $327,000
Q1 2024

May 15, 2024

BUY
$26.4 - $32.56 $546,480 - $673,992
20,700 New
20,700 $560,000
Q3 2023

Nov 15, 2023

BUY
$27.17 - $31.97 $301,587 - $354,867
11,100 New
11,100 $310,000
Q1 2023

May 15, 2023

BUY
$25.31 - $29.02 $174,639 - $200,238
6,900 Added 65.09%
17,500 $487,000
Q4 2022

Feb 14, 2023

BUY
$21.94 - $26.24 $232,564 - $278,144
10,600 New
10,600 $277,000
Q2 2022

Aug 15, 2022

SELL
$26.4 - $30.54 $84,480 - $97,728
-3,200 Reduced 31.68%
6,900 $209,000
Q1 2022

May 16, 2022

SELL
$23.07 - $27.99 $136,113 - $165,141
-5,900 Reduced 36.88%
10,100 $268,000
Q4 2021

Feb 14, 2022

BUY
$21.47 - $32.08 $122,379 - $182,856
5,700 Added 55.34%
16,000 $374,000
Q1 2021

May 14, 2021

SELL
$18.21 - $23.2 $27,315 - $34,800
-1,500 Reduced 12.71%
10,300 $193,000
Q4 2020

Feb 12, 2021

BUY
$15.39 - $22.1 $181,602 - $260,780
11,800 New
11,800 $241,000
Q1 2020

May 11, 2020

SELL
$13.06 - $21.24 $137,130 - $223,019
-10,500 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$17.29 - $21.74 $181,545 - $228,269
10,500 New
10,500 $211,000
Q3 2019

Nov 14, 2019

SELL
$19.51 - $24.28 $308,258 - $383,624
-15,800 Closed
0 $0
Q2 2019

Aug 20, 2019

SELL
$21.47 - $37.33 $113,791 - $197,849
-5,300 Reduced 25.12%
15,800 $356,000
Q1 2019

May 15, 2019

SELL
$28.4 - $36.49 $1.05 Million - $1.35 Million
-36,900 Reduced 63.62%
21,100 $770,000
Q4 2018

Feb 14, 2019

BUY
$27.94 - $44.61 $19,558 - $31,227
700 Added 1.22%
58,000 $1.65 Million
Q3 2018

Nov 14, 2018

BUY
$38.6 - $46.12 $2.21 Million - $2.64 Million
57,300 New
57,300 $2.43 Million
Q1 2018

May 15, 2018

SELL
$53.61 - $67.26 $1.31 Million - $1.64 Million
-24,400 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$47.69 - $55.39 $1.16 Million - $1.35 Million
24,400
24,400 $1.34 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.05B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.